SMO and acute myeloid leukemia: Another SMO antagonist glasdegib, also known as PF-04449913, is being tested in patients with acute myeloid leukemia (AML) [58] and in combination with nucleoside analog Azacitidine for other hematologic malignancies such as chronic myelomonocytic leukemia [59].